Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
Catheter Cardiovasc Interv. 2018 Sep 1;92(3):497-504. doi: 10.1002/ccd.27470. Epub 2018 Jan 4.
To describe and evaluate the efficacy of a novel antegrade dissection/re-entry (ADR) technique, called antegrade fenestration and re-entry (AFR), for chronic total occlusions (CTO) percutaneous coronary intervention (PCI).
The widespread adoption of ADR is limited by several technical, logistic, and financial factors. Therefore, novel ADR techniques are needed.
AFR consists in creating multiple fenestrations of the dissection flap separating the false and true lumen. This is achieved by advancing a balloon (sized 1:1 with the artery diameter) onto the antegrade wire into the subintimal space, and inflating it at the level of the distal cap. A soft polymer-jacketed guidewire is then advanced across the fenestrations created by balloon inflation from the subintimal space into the true lumen. Following its theoretical formulation, patients undergoing ADR-based CTO recanalization at our institution were considered for AFR treatment.
Between November 2015 and October 2017, 279 CTO PCIs were performed. Of those, ADR was utilized in 33 (12%) cases, of whom AFR was used in 6 (18%). In all but one cases, AFR was performed after failed true-to-true lumen crossing, while in the remainder it was utilized after extensive subintimal space disruption following alternative ADR techniques. AFR was successful in all six cases and no complications were observed.
We have developed a novel ADR technique which aims at complementing the CTO operator's armamentarium. AFR does not preclude alternative bailout techniques, and is inexpensive and easy to perform. A dedicated study should confirm our findings in a large cohort.
描述和评估一种新的顺行夹层/再入(ADR)技术,称为顺行开窗和再入(AFR),用于慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)。
ADR 的广泛采用受到技术、后勤和财务等多种因素的限制。因此,需要新的 ADR 技术。
AFR 包括在分隔真假腔的夹层瓣上创建多个窗孔。这是通过将球囊(与动脉直径 1:1)推进到顺行导丝进入内膜下空间,并在远端帽水平上充气来实现的。然后,将软聚合物护套导丝从内膜下空间穿过球囊充气形成的窗孔推进到真腔。根据其理论表述,在我们的机构中,接受基于 ADR 的 CTO 再通的患者被考虑接受 AFR 治疗。
2015 年 11 月至 2017 年 10 月,共进行了 279 例 CTO PCI。其中,33 例(12%)采用了 ADR,其中 6 例(18%)采用了 AFR。除 1 例外,所有病例均在真腔至真腔交叉失败后进行 AFR,其余病例均在替代 ADR 技术后广泛内膜下空间破坏后进行。AFR 在所有 6 例中均成功,未观察到并发症。
我们开发了一种新的 ADR 技术,旨在补充 CTO 操作者的武器库。AFR 不排除替代的救生技术,并且价格低廉且易于实施。应进行专门的研究以在大样本中证实我们的发现。